stockportfolio.pro
Stocks / CORT vs UHS
CORT vs UHS
Corcept Therapeutics Incorporated and Universal Health Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
UHS is the larger company ($8.6B vs $8.4B). On the fundamentals, CORT grows revenue faster (16.6% vs 8.5%); CORT earns a higher net margin (12.9% vs 8.6%); UHS has the stronger return on equity (20.5% vs 15.2%). Full numbers below — the stronger figure on each row is in green.
| Corcept Therapeutics Incorporated (CORT) | Universal Health Services, Inc. (UHS) | |
|---|---|---|
| Market cap | $8.4B | $8.6B |
| Revenue (latest FY) | $761.41M | $17.36B |
| Net income (latest FY) | $98.17M | $1.49B |
| Revenue growth (5y CAGR) | 16.6% | 8.5% |
| Net margin | 12.9% | 8.6% |
| Return on equity | 15.2% | 20.5% |
| P/E ratio | 222.6 | 5.9 |
| Dividend yield | — | 0.5% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full CORT vs UHS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CORT's full financials → Open UHS's full financials →More comparisons
Frequently asked questions
Which is bigger, CORT or UHS?
Universal Health Services, Inc. is larger by market capitalization — $8.6B versus $8.4B.
Which grows faster, CORT or UHS?
Over the last five fiscal years, Corcept Therapeutics Incorporated grew revenue faster — 16.6%/yr versus 8.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.